PRO131921(RhuMAb; v114)Phase I/II  GenentechType ImAb  HumanizedIgG1(Engineered Fcportion)  PRO131921, 25–800 (24 patients of Relapsed/refractory B cell NHL,ORR 27%) [98]  High CDCLow ADCC